Therefore, although ablation of Chop and Ask1 do not preserve overall functional response of the retina, the benefits of targeting the UPR in treating RP may be more apparent during later stages of the disease when the difference in the number of photoreceptors remaining is between no cells to one or two rows of cells. This evidence concerns the gene DDIT3 and retinitis pigmentosa 1.